Home

Headlines Weather Search

News

Sports

Business

World

Radio

Radio Fiji One Mirchi FM Gold FM Bula FM 2Day FM Radio Fiji Two

TV

FBC TV FBC Sports FBC 2

World

Brazil trial finds efficacy of Sinovac vaccine at 50.4 percent

January 13, 2021 3:39 pm
An employee holds a vial containing Sinovac Biotech's vaccine against COVID-19 at the Butantan biomedical production centre in Sao Paulo. [Source: Aljazeera]

A coronavirus vaccine developed by China’s Sinovac Biotech was found to be just 50.4 percent effective at preventing symptomatic infections of COVID-19 in a Brazilian trial.

This is barely enough for regulatory approval and well below the rate announced last week.

The latest results are a substantial disappointment for Brazil, as the Chinese vaccine is one of two that the federal government has lined up to begin immunization during the second wave of the world’s second-deadliest COVID-19 outbreak.

Article continues after advertisement

Keep Connected With The Latest News, Weather, And Sports on Fiji's Best Radio stations.

Live Tune In
  • 95.4 FM
  • Suva, Nadi, Lautoka, Labasa
  • 95.2 FM
  • Sigatoka, Ba
  • 95.6 FM
  • Tavua
  • 95.8 FM
  • Rakiraki
Live Tune In
  • 102.6 FM
  • Suva, Nadi, Lautoka, Labasa
  • 102.4 FM
  • Sigatoka, Ba
  • 102.8 FM
  • Tavua
  • 103.0 FM
  • Rakiraki
Live Tune In
  • 97.8 FM
  • Suva, Nadi, Lautoka, Labasa
  • 97.6 FM
  • Sigatoka, Ba
  • 98.0 FM
  • Tavua
  • 98.2 FM
  • Rakiraki
Live Tune In
  • 93.0 FM
  • Suva, Nadi, Lautoka, Labasa
  • 92.8 FM
  • Sigatoka, Ba
  • 93.2 FM
  • Tavua
  • 93.4 FM
  • Rakiraki
Live Tune In
  • 100.2 FM
  • Suva, Nadi, Lautoka, Labasa
  • 100.0 FM
  • Sigatoka, Ba
  • 100.4 FM
  • Tavua
  • 100.6 FM
  • Rakiraki
Live Tune In
  • 105.0 FM
  • Suva, Nadi, Lautoka, Labasa
  • 104.8 FM
  • Sigatoka, Ba
  • 105.2 FM
  • Tavua
  • 105.4 FM
  • Rakiraki